Planning

PHE - Corporate - Supporting Prospective AI trials in Breast Screening

PUBLIC HEALTH ENGLAND

This public procurement record has 1 release in its history.

Planning

09 Mar 2021 at 10:58

Planned Procurement Notice
Summary of the contracting process

The procurement process is being conducted by Public Health England (PHE) for the tender titled "PHE - Corporate - Supporting Prospective AI trials in Breast Screening". This initiative falls under the administrative healthcare services category and is located in London, England. Currently in the planning stage, this tender is focused on organising an engagement day scheduled for 21st April 2021, where interested AI companies can discuss their requirements for future trials within the NHS Breast Cancer Screening Programme. The contract period is set to begin on 1st September 2022 and will conclude on 31st March 2023, with a future notice date for potential suppliers being 9th March 2021.

This tender presents significant opportunities for AI companies specialising in the healthcare sector. Businesses that are developing or planning to conduct research on AI products applicable to NHS services in breast screening are encouraged to participate. The engagement day will facilitate a collaborative approach to understand IT system requirements and streamline trial processes, making it an excellent platform for companies looking to influence national healthcare delivery and further their involvement in NHS-funded projects.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

PHE - Corporate - Supporting Prospective AI trials in Breast Screening

Notice Description

Artificial Intelligence (AI) companies are starting to be granted funding by the Accelerated Access Collaborative (AAC) for evaluating their AI products in the NHS Breast Cancer Screening Programme (NHS BSP). Public Health England (PHE) are keen to support these studies in a way that benefits the programme and minimises the risk for operational services and IT systems. For this reason, PHE are arranging an engagement day with AI companies known to the programme to understand what the likely demands on the NHS BSP IT systems will be from future studies. Interested parties will be invited to a 1hr private session to discuss their expected requirements. This will take place on Wednesday 21st April 2021. You will be allocated a timeslot when we know how many parties are interested. Additional information: Artificial Intelligence (AI) companies are starting to be granted funding by the Accelerated Access Collaborative (AAC) for evaluating their AI products in the NHS Breast Cancer Screening Programme (NHS BSP). Public Health England (PHE) are keen to support these studies in a way that benefits the programme and minimises the risk for operational services and IT systems. For this reason, PHE are arranging an engagement day with AI companies known to the programme to understand what the likely demands on the NHS BSP IT systems will be from future studies. Interested parties will be invited to a 1hr private session to discuss their expected requirements. This will take place on Wednesday 21st April 2021. You will be allocated a timeslot when we know how many parties are interested. Objective of the engagement session To understand how each company's AI product: - would sit within the screening pathway - would interact with the existing screening NHS BSP IT systems. - would be tested in the NHS BSP Format There is a need to ensure that AI study project teams understand how breast screening services work and how the existing IT systems and data flows support this. Teams will be provided with a summary of the existing IT systems and will be given the opportunity to ask questions and discuss their structures and functions. This includes the varying combinations of national and locally owned systems and infrastructure and is essential to inform whether studies can be supported by the existing systems. The teams will then be invited to present their study plan and expected requirements from the NHS BSP and IT systems, followed by questions and clarifications from PHE/ NHSEI/ NHSX The present supplier of the NBSS (Hitachi Vantara) will attend the day to provide feedback on the technical feasibility of options that AI study project teams discuss. Non-Disclosure Agreements may be used if required. Outcome Once all parties' requirements are understood, PHE will use this to establish the likely requirements of AI companies seeking to undertake research within the NHS BSP. The hope is to establish similarities between other studies so that a generalisable IT and delivery approach to trials/requirements can be identified. Depending on the requirements sought, any necessary changes to the IT systems will need to be technically assessed for feasibility and reviewed based on the limited resource capacity of the programme. If feasible, the work to make changes to the NHS BSP IT systems will need to be prioritised, funded and resourced, with costs being covered fairly by the companies requiring such changes. Companies who are planning or participating in research on an AI product which will potentially affect national NHS BSP service delivery within the next 18 months can get in touch through Screening.Research@phe.gov.uk

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-b54bd9b0-6a01-4b36-9cb6-64b7af973142
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/7e013850-d904-4fda-9f34-1213d80f8649
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Planned Procurement Notice
Procurement Type
Standard
Procurement Category
Not specified
Procurement Method
Not Specified
Procurement Method Details
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

75 - Administration, defence and social security services

CPV Codes

75122000 - Administrative healthcare services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
9 Mar 20214 years ago
Submission Deadline
Not specified
Future Notice Date
9 Mar 2021Expired
Award Date
Not specified
Contract Period
31 Aug 2022 - 31 Mar 2023 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
PUBLIC HEALTH ENGLAND
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Post Town
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
Not specified
Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-b54bd9b0-6a01-4b36-9cb6-64b7af973142-2021-03-09T10:58:42Z",
    "date": "2021-03-09T10:58:42Z",
    "ocid": "ocds-b5fd17-b54bd9b0-6a01-4b36-9cb6-64b7af973142",
    "language": "en",
    "initiationType": "tender",
    "planning": {
        "documents": [
            {
                "id": "1",
                "documentType": "plannedProcurementNotice",
                "description": "Future opportunity notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/7e013850-d904-4fda-9f34-1213d80f8649",
                "datePublished": "2021-03-09T10:58:42Z",
                "format": "text/html",
                "language": "en"
            },
            {
                "id": "2",
                "documentType": "tenderNotice",
                "description": "Prior Information Notice.",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/dbdca9a0-b302-452b-86b7-8353b5a907df",
                "format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document"
            }
        ]
    },
    "tender": {
        "id": "tender_266326/931873",
        "title": "PHE - Corporate - Supporting Prospective AI trials in Breast Screening",
        "description": "Artificial Intelligence (AI) companies are starting to be granted funding by the Accelerated Access Collaborative (AAC) for evaluating their AI products in the NHS Breast Cancer Screening Programme (NHS BSP). Public Health England (PHE) are keen to support these studies in a way that benefits the programme and minimises the risk for operational services and IT systems. For this reason, PHE are arranging an engagement day with AI companies known to the programme to understand what the likely demands on the NHS BSP IT systems will be from future studies. Interested parties will be invited to a 1hr private session to discuss their expected requirements. This will take place on Wednesday 21st April 2021. You will be allocated a timeslot when we know how many parties are interested. Additional information: Artificial Intelligence (AI) companies are starting to be granted funding by the Accelerated Access Collaborative (AAC) for evaluating their AI products in the NHS Breast Cancer Screening Programme (NHS BSP). Public Health England (PHE) are keen to support these studies in a way that benefits the programme and minimises the risk for operational services and IT systems. For this reason, PHE are arranging an engagement day with AI companies known to the programme to understand what the likely demands on the NHS BSP IT systems will be from future studies. Interested parties will be invited to a 1hr private session to discuss their expected requirements. This will take place on Wednesday 21st April 2021. You will be allocated a timeslot when we know how many parties are interested. Objective of the engagement session To understand how each company's AI product: - would sit within the screening pathway - would interact with the existing screening NHS BSP IT systems. - would be tested in the NHS BSP Format There is a need to ensure that AI study project teams understand how breast screening services work and how the existing IT systems and data flows support this. Teams will be provided with a summary of the existing IT systems and will be given the opportunity to ask questions and discuss their structures and functions. This includes the varying combinations of national and locally owned systems and infrastructure and is essential to inform whether studies can be supported by the existing systems. The teams will then be invited to present their study plan and expected requirements from the NHS BSP and IT systems, followed by questions and clarifications from PHE/ NHSEI/ NHSX The present supplier of the NBSS (Hitachi Vantara) will attend the day to provide feedback on the technical feasibility of options that AI study project teams discuss. Non-Disclosure Agreements may be used if required. Outcome Once all parties' requirements are understood, PHE will use this to establish the likely requirements of AI companies seeking to undertake research within the NHS BSP. The hope is to establish similarities between other studies so that a generalisable IT and delivery approach to trials/requirements can be identified. Depending on the requirements sought, any necessary changes to the IT systems will need to be technically assessed for feasibility and reviewed based on the limited resource capacity of the programme. If feasible, the work to make changes to the NHS BSP IT systems will need to be prioritised, funded and resourced, with costs being covered fairly by the companies requiring such changes. Companies who are planning or participating in research on an AI product which will potentially affect national NHS BSP service delivery within the next 18 months can get in touch through Screening.Research@phe.gov.uk",
        "status": "planned",
        "classification": {
            "scheme": "CPV",
            "id": "75122000",
            "description": "Administrative healthcare services"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "countryName": "British Oversea Territories"
                    },
                    {
                        "countryName": "Channel Islands"
                    },
                    {
                        "countryName": "Europe"
                    },
                    {
                        "countryName": "Isle of Man"
                    },
                    {
                        "countryName": "Rest of the World"
                    },
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "communication": {
            "futureNoticeDate": "2021-03-09T23:59:59Z"
        },
        "contractPeriod": {
            "startDate": "2022-09-01T00:00:00+01:00",
            "endDate": "2023-03-31T23:59:59+01:00"
        },
        "suitability": {
            "sme": true,
            "vcse": false
        }
    },
    "parties": [
        {
            "id": "GB-CFS-82416",
            "name": "Public Health England",
            "identifier": {
                "legalName": "Public Health England"
            },
            "address": {
                "streetAddress": "Wellington House, 133-155 Waterloo Road",
                "locality": "London",
                "postalCode": "SE1 8UG",
                "countryName": "England"
            },
            "contactPoint": {
                "email": "Screening.Research@phe.gov.uk"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-82416",
        "name": "Public Health England"
    }
}